Added to YB: 2026-03-04
Pitch date: 2026-02-27
TSTL.L [neutral]
Tristel plc
-6.17%
current return
Author Info
Increasing Odds shares their investment journey in their newsletter. Sign up for the newsletter.
Company Info
Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally.
Market Cap
GBP 191.7M
Pitch Price
GBP 4.05
Price Target
N/A
Dividend
N/A
EV/EBITDA
14.55
P/E
24.63
EV/Sales
3.72
Sector
Health Care Equipment and Supplies
Category
growth
AIM A-Z Part 36: Potential Exit, Buybacks, Adjustments - Pass: Tristel plc
TSTL.L (pass): £196M infection prevention co, 14% rev growth, 28% EBITDA margin in H1. Expanding to Spain/India/Austria, US focus. Quality financials: 3.5% dividend, consistent growth, stable margins. Trading 23x fwd P/E. Concerns: CEO departure after joining late 2024, multiple mgmt changes, share dilution, 27% rev from 1 customer.
Read full article (1 min)